Alpha Teknova, Inc. (NASDAQ: TKNO) is a life sciences company headquartered in Fremont, California, focused on the development, manufacture and distribution of high-performance reagents and kits for molecular biology, next-generation sequencing (NGS) and bioprocessing. The company’s core product portfolio includes custom and off-the-shelf enzymes, buffers, nucleic acid purification systems and sequencing library preparation kits designed to meet the rigorous requirements of academic research, pharmaceutical development and industrial biotechnology applications.
Alpha Teknova’s NGS offerings encompass a range of library preparation solutions, indexing primers and QC assays, enabling customers to streamline workflows from sample preparation through sequencing. In addition to sequencing reagents, the company provides a broad selection of polymerases, reverse transcriptases and DNA/RNA ligases, all manufactured under stringent quality controls. Its bioprocessing line features cell culture media, feed supplements and chromatography resins tailored for biologics production, reflecting the company’s capability to serve both small-scale research and cGMP-compliant manufacturing environments.
The company’s products are marketed through direct sales channels in North America and a network of distributors across Europe, Asia-Pacific and other international markets. Alpha Teknova maintains R&D and production facilities in California, leveraging scalable manufacturing processes to support rapidly evolving customer demands. Collaboration with academic institutions, contract research organizations and large pharmaceutical companies underpins ongoing innovation in areas such as single-cell sequencing, digital PCR and advanced synthetic biology workflows.
Founded in 2001, Alpha Teknova has grown from a niche supplier of biochemical reagents into a diversified platform serving the genomics and bioprocessing sectors. The company is led by CEO Aravind Kaushik, who brings over two decades of experience in the life sciences industry, supported by a management team with deep expertise in research, manufacturing and global commercialization. Under this leadership, Alpha Teknova continues to expand its footprint in key markets while investing in new technologies that address emerging needs in molecular diagnostics and biologics production.
AI Generated. May Contain Errors.
Free TKNO Stock Alerts